Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on C Acid. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Overcome low yield and high purification costs in vilanterol synthesis. New succinic acid salt method achieves 76% yield, 99.6% purity, and <0.1% S-isomer. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve high-cost, low-yield issues in minodronic acid synthesis. New halogenation-Grignard method offers 83-88% yield, no toxic reagents, and scalable production for osteoporosis drugs.
Solve high-toxicity reagent risks and multi-step costs in pyridine intermediate synthesis. New one-step method boosts yield to 87.5% with 97.5% purity, reducing solvent use and scaling challenges.
Discover how this novel nickel complex with 75% yield in key step enables stable electrochemical performance for modified electrodes. Reduce supply chain risks with scalable synthesis.
Solve regioselectivity challenges in carboxylic acid synthesis with 96% yield. NINGBO INNO PHARMCHEM offers scalable, cost-effective production for your API development.
Reduce production costs and metal residues with this efficient photocatalytic route for high-purity o-amino aromatic ketones in drug development.
Discover N-N axis chiral indole-pyrrole synthesis with 97% ee, reducing R&D costs and supply chain risks for asymmetric pharmaceutical catalysts.
Discover a scalable, high-ee synthesis method for N-N axis chiral indole-pyrrole compounds. Ideal for chiral catalyst development with 97% ee and 62% yield. Reduce R&D costs and supply chain risks.
Avoid toxic AIBN and expensive ligands with this green iron-catalyzed method. Achieve 75%+ yields in mild conditions for stable API supply chains.
Solve supply chain risks with this 3-step, column-free synthesis of 5-ethyl-2-pyrrole carboxylic acid. 92% yield, no chromatography, and scalable to 100MT/yr. Contact for COA/MSDS.
Solve bromine impurity challenges in prucalopride synthesis. Our optimized recrystallization method achieves >99.8% purity and 93% yield, reducing supply chain risks for API manufacturers.
Solve chiral purity challenges in halichondrin synthesis. Our CDMO expertise delivers >99% ee intermediates with 92% yield, reducing impurity risks for oncology drug development.
Solve supply chain challenges for (Z)-2-acetylaminocinnamic acid methyl ester with 68%+ yield, 99%+ purity, and no column chromatography. Industrial-scale production ready.
Solve aryl boronic acid synthesis challenges with thiosilane ligand: 80-86% yield, simplified purification, and industrial scalability for pharma intermediates.
Solve low yield and purification challenges in arylboronic acid synthesis. Our CDMO expertise scales thiosilane ligand technology for 99% purity and cost efficiency.
Discover scalable chiral indolinopyrrole synthesis with 99% ee and 90%+ yield. Ideal for oncology drug development. Reduce costs and supply chain risks.
Solve axial chiral synthesis challenges with high-yield, mild-condition process. Reduce R&D costs and supply chain risks for asymmetric catalysts.
High-yield, high-ee synthesis of non-natural amino acids with water as proton source. Reduce production costs and supply chain risks for API manufacturing.
Solve supply chain risks in chiral synthesis with this novel protonic acid catalyst. Achieve 98% ee and 96% yield in ruthenium-catalyzed reactions. Contact us for custom synthesis.
Solve epimer impurity challenges in biotin production. New method achieves 99.8% conversion with 1.3% optical isomer ratio, reducing purification steps and costs.